Skip to main content

SB 2499 — Tennessee

TennCare - As introduced, requires a managed care organization or pharmacy benefits manager that is contracted with the bureau to reimburse a claim for a long-acting injectable drug intended for treatment and prevention of human immunodeficiency virus and administered in a pharmacy, physician's office, clinic, ambulatory surgical treatment center, or hospital. - Amends TCA Title 4; Title 56 and Title 71.

Introduced 114 session Senate

This page lists STATE bills only. Open States, our source for this data, tracks state legislatures -- it has no visibility into city councils, county commissions or school boards. We don't yet have a free, storable source for local measures; see the About page for why.

Summary

  • SB 2499 is a bill in the Tennessee Senate, 114 session, introduced February 2, 2026.
  • Sponsored by Kyle.
  • Current status: introduced.
  • Most recent action (March 10, 2026): Assigned to General Subcommittee of Senate Commerce and Labor Committee.
  • Subjects: TennCare.

Contact your legislator about this bill

Bill text & documents

Sponsors

Primary: Kyle

History

  1. Introduced, completed
  2. Passed Senate, in progress
  3. Passed House, not reached yet
  4. Sent to Governor, not reached yet
  5. Signed into law, not reached yet
  1. Senate Refer to Senate Delayed Bills Committee
  2. Senate Filed for introduction
  3. Senate Introduced, Passed on First Consideration Milestone
  4. Senate Approved by Delayed Bills Committee
  5. Senate Placed on Senate Commerce and Labor Committee calendar for 3/10/2026
  6. Senate Passed on Second Consideration, refer to Senate Commerce and Labor Committee
  7. Senate Assigned to General Subcommittee of Senate Commerce and Labor Committee Latest

Source: Open States. Last checked November 10, 2026. How we keep this accurate ›